F1 Pharma S.A.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2019-08-06
Share capital
1,669,800.00 PLN
Activity description

F1 Pharma provides research and development services for the pharmaceutical industry. The company works in pharmaceutical technology, analytics, stability testing, and quality assurance. It also carries out comprehensive development of medicinal products, including new drug forms.

Registered address
ul. Profesora Michała Bobrzyńskiego 14, 30-348 Kraków, Poland
Email
Phone
Electronic delivery address
AE:PL-17662-97685-DAFHE-10

Financials

Revenue history (in k)

From the notes

Current income tax (CIT due)$1,679

Filing timeliness

2 of 6 financial statements were filed late (the longest delay 89 days for 2021). All were audited by a statutory auditor.

  • 202514/07/2026
  • 202429/08/2025
  • 202309/07/2024
  • 202212/07/2023
  • 202112/10/2022
  • 202028/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 69%
Sector · Manufacturing17,166 / 24,548
Top 70%
City · Kraków7,466 / 16,145
Top 46%
Voivodeship · Małopolskie13,956 / 27,724
Top 50%
Country · Poland151,310 / 297,069
Top 51%

Results vs industry

Revenue
This companyUSD 272.11kMedianUSD 913.43kAverageUSD 25.82m
Net profit
This companyUSD 25.45kMedianUSD 14.22kAverageUSD 2.77m
Operating costs
This companyUSD 238.76kMedianUSD 846.99kAverageUSD 21.42m
Assets
This companyUSD 203.79kMedianUSD 897.46kAverageUSD 31.52m

Offer

Certifications: GMP

Websites

  • f1pharma.plF1Pharma – rozwiązania badawczo-rozwojowe dla przemysłu farmaceutycznego
    Nginx

Job offers

The company lists 1 job opening on its own careers page: f1pharma.pl/kariera.

Position
Specialist analyst

Authorized Representatives

Mirosław Marek Strózik age 63 – President of the Management Board

Manner of representation

The company is represented by two members of the management board acting jointly.

Supervisory board

Krzysztof Flak age 44 – Supervisory Board Member
Piotr Pątko age 58 – Supervisory Board Member
Paweł Szydłowski age 46 – Supervisory Board Member

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2010-11-17.

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication dateEvent
Apr 4, 2024Shareholders' meeting convened
Dec 11, 2020Commercial Companies Code notice
Nov 26, 2020Commercial Companies Code notice
Oct 26, 2020Commercial Companies Code notice
Oct 9, 2020Commercial Companies Code notice

Public aid

9 public aid cases recorded, with a total value of $1,035,930.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$79,573
Aid for research and development projects: industrial research
$488.6K
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$93,524

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Pikralida sp. z o.o.
MT Laboratories sp. z o.o.
Mikrografia sp. z o.o.
Green Zebras S.A.
Medicofarma Biotech S.A.
Albi-Tech sp. z o.o.
Globe Badania Kliniczne sp. z o.o.
Genelytica sp. z o.o.
TCI sp. z o.o.
Rebread Alcohol & Beverages sp. z o.o.

FAQ

Last updated: 2026-10-03